New targeted approach to light-activated cancer drugs

Combining light-activated cancer drugs with tumour-seeking antibodies could provide a more effective way of treating many cancers, according to new research published in advance online in the International Journal of Cancer.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news113753147.html">New targeted approach to light-activated cancer drugs</a></p> <p>Combining light-activated cancer drugs with tumour-seeking antibodies could provide a more effective way of treating many cancers, according to new research published in advance online in the <i>International Journal of Cancer</i>.</p>